“Maternal Hyperoxygenation in Congenital Heart Disease”
A pilot study investigating the safety and feasibility of chronic maternal hyperoxygenation in the setting of fetal congenital heart disease
Drug - Maternal Hyperoxygenation
Oxygen via nasal prongs at 4L/min continuously during 2nd and 3rd trimester of pregnancy until birth
Maternal Hyperoxygenation in Congenital Heart Disease
NCT03136835
QdJk2e